New research identifies blood-based B cell and antibody signatures that could guide safer treatment for patients receiving immunotherapy.
2025
Study Shows that Existing Drug Class May Help Patients with Skin Cancer that Resists Standard Treatments
ncreased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new study shows.
EGFR Inhibitors Could Be Effective Treatment for NF1 Melanoma Subtype
A team of researchers at NYU Langone Health and the Perlmutter Cancer Center has identified a potential therapeutic strategy for melanoma patients whose tumors harbor mutations in the neurofibromin 1 (NF1) gene and who do not respond to current immunotherapy treatments.
Could AI help doctors better detect melanoma?
New research shows how artificial intelligence could result in more rapid and accurate diagnoses of melanoma and other skin conditions.